Feedback
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
CORRECT!
Faculty & Disclosures
Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, MA, USA
Dr Morgans is an associate professor of medicine at Harvard Medical School, a genitourinary medical oncologist and the director of the Survivorship Program at Dana-Farber Cancer Institute. read more
As a clinician and investigator, Dr Morgans has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic and cognitive complications, and her work has been funded by grants from the Prostate Cancer Foundation, the National Comprehensive Cancer Network and the Department of Defense. She leads multiple therapeutic and quality of life focused clinical trials for patients with prostate cancer. She has participated in committees of the American Urologic Association and the cardio-oncology committee of the American Heart Association for the development of advanced and localized prostate cancer treatment guidelines.
Dr Alicia Morgans discloses: Consultant/advisory fees from AAA, Astellas, AstraZeneca, Bayer, Curium, Exelixis, Janssen, Lantheus, Macrogenics, Merck, Novartis, Pfizer, Telix and Tolmar. Grant/research support fees from AAA, Astellas, Janssen, Lantheus, Novartis and Pfizer.
Prof. Albrecht Stenzinger
University of Heidelberg, Heidelberg, Germany
Albrecht Stenzinger is professor of molecular tumour pathology, vice chair of the Institute of Pathology (IPH), as well as the director of the IPH Centre for Molecular Pathology (CMP) and section head for molecular diagnostics and biomarker development at the Institute of Pathology, University Hospital Heidelberg, Germany. read more
Dr Stenzinger holds an MD degree from the University of Giessen, completed his residency and fellowship training in pathology at the Charité University Hospital, Berlin and the University Hospital Heidelberg. He is a board-certified surgical pathologist, molecular pathologist and senior attending. Dr Stenzinger received postdoctoral training at the University of Heidelberg and Massachusetts General Hospital/Harvard Medical School, USA.Â
He has broad expertise in molecular pathology as well as molecular diagnostics and works in the field of translational research and genetics of solid tumours.
Prof. Albrecht Stenzinger discloses: Advisory board or panel fees from Agilent, Aignostics, Amgen, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eli Lilly, Illumina, Incyte, Janssen, MSD, Novartis, Pfizer, Qlucore, QuiP, Roche, Sanofi, Seagen, Servier, Takeda and Thermo Fisher. Grant/research support fees from Bayer, Bristol Myers Squibb, Chugai, Incyte and MSD.
Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, MI, USA
Grace Cullen, DNP, FNP-BC, AOCNP, PMGT-BC, FPCN, is a haematology/oncology and palliative care nurse practitioner at the Detroit VA Medical Center. read more
Dr Cullen is an adjunct clinical instructor for the advance practice programme of the Wayne State University College of Nursing. She is a clinical investigator with a research focus on cancer and end-of-life care. She is a reviewer for the Clinical Investigations Committee of the Detroit VA.Â
Dr Cullen has multiple peer-reviewed journal publications and presentations on palliative care and oncology, as well as chapter contributions in various reference textbooks. She also serves as a manuscript reviewer for various peer-reviewed journals.Â
She is a recipient of the Outstanding Advance Practice Nurse of the Year and EBP Award from the Metro Detroit Oncology Nursing Society, the DVA Secretary’s Excellence in Nursing Award, the DAISY Award for Extraordinary Nurses, the Excellence in Clinical Research and Exemplary Contribution awards from the Detroit VA, and the Volunteerism Award from the Hospice and Palliative Nurses Association.Â
She is a member of the board of directors, co-chair of the Palliative Care SIG, and an abstract reviewer for the Association of VA Hematology and Oncology. She is director-at-large for the Metro Detroit Oncology Nursing Society. She is an item writer for the advance oncology nursing practice certification exam by the Oncology Nursing Credentialing Center. She has led QI initiatives increasing palliative care involvement among veterans with stage III lung cancer and stage IV malignancies, as well as improving prostate germline genetic testing at the Detroit VA.
Dr Grace Cullen has no interests/relationships or affiliations to disclose in relation to this activity.
Mr Tony Collier
Tackle Prostate Cancer, London, UK
Tony is an ambassador, awareness speaker, volunteer and fundraiser for Prostate Cancer UK. He is also a trustee of Tackle Prostate Cancer, who are responsible for supporting all prostate cancer support groups across the UK. read more
Tony was diagnosed with advanced stage prostate cancer in 2017. He had a PSA of 129, Gleason 9 with metastases throughout his skeleton from pelvis to skull.
Tony is a consultant to Bennett Brooks Chartered Accountants, who recently acquired the practice he was managing partner of prior to his illness. He was, until recently, the provost (think unelected mayor) of his home town Altrincham and was awarded a British Empire Medal in the Queen’s 2019 birthday honours, recognising his work in the regeneration of Altrincham and charity fundraising for local charities.
Tony is also an ambassador and regional champion for 5K Your Way, a peer-to-peer support group encouraging those living with and beyond cancer to exercise and part of the Move Against Cancer charity. Prior to his diagnosis, Tony was a good-standard club runner training to take on one of the world’s toughest ultramarathons. He’s completed 20 marathons, including all six World Marathon Majors, and two ultramarathons. He continues to run and achieve things that people without stage IV prostate cancer would struggle to do!
Tony is married to Tracey and has two children and four grandchildren who are a massive part of his post cancer diagnosis life.
Mr Tony Collier discloses: Speaker fees from AstraZeneca, Bayer and MSD.
